[
  {
    "ts": null,
    "headline": "Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",
    "summary": "Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.",
    "url": "https://finnhub.io/api/news?id=55d1529df95faa211f30c69c3af5c9bc27914aaccba3736ed4c24b15134a2681",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734134056,
      "headline": "Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",
      "id": 131977467,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.",
      "url": "https://finnhub.io/api/news?id=55d1529df95faa211f30c69c3af5c9bc27914aaccba3736ed4c24b15134a2681"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=ba73a2872f679b5cd63acab44d7010c3cfa503d02335518339ebca9c02c728fa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734107700,
      "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "id": 132065121,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=ba73a2872f679b5cd63acab44d7010c3cfa503d02335518339ebca9c02c728fa"
    }
  },
  {
    "ts": null,
    "headline": "Merck Receives Positive EU CHMP Opinion for WELIREG® (belzutifan) as Treatment for Adult Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma",
    "summary": "RAHWAY, N.J., December 13, 2024--WELIREG CHMP Opinion for VHL & RCC",
    "url": "https://finnhub.io/api/news?id=d48d58368c3d69896f257b40496ba079d0fc0ede9c2ca16e299722d02498f0e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734091500,
      "headline": "Merck Receives Positive EU CHMP Opinion for WELIREG® (belzutifan) as Treatment for Adult Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma",
      "id": 131966988,
      "image": "https://media.zenfs.com/en/business-wire.com/2b71d7dbe02738d5c8e95b07ced3bfac",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., December 13, 2024--WELIREG CHMP Opinion for VHL & RCC",
      "url": "https://finnhub.io/api/news?id=d48d58368c3d69896f257b40496ba079d0fc0ede9c2ca16e299722d02498f0e2"
    }
  },
  {
    "ts": null,
    "headline": "Merck: receives a positive opinion from the CHMP on Welireg",
    "summary": "Merck announces that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for the conditional approval of Welireg , an oral HIF-2α...",
    "url": "https://finnhub.io/api/news?id=d4d377115e9c0fa4a244b93b7cbb2612e1ea97388f942435c5443404d25989e0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734080172,
      "headline": "Merck: receives a positive opinion from the CHMP on Welireg",
      "id": 131965765,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck announces that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion for the conditional approval of Welireg , an oral HIF-2α...",
      "url": "https://finnhub.io/api/news?id=d4d377115e9c0fa4a244b93b7cbb2612e1ea97388f942435c5443404d25989e0"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Gets Key European Backing for Welireg in Two Uses",
    "summary": "By Colin Kellaher Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications. Merck on Friday said the...",
    "url": "https://finnhub.io/api/news?id=5e67508313d3e187e7ee03353f332bc35d051e413737d2462afcd29d794a49c4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734075972,
      "headline": "Merck & Co. Gets Key European Backing for Welireg in Two Uses",
      "id": 131964760,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Merck & Co. said a key European regulatory committee has recommended conditional approval of its Welireg oral cancer drug in a pair of indications. Merck on Friday said the...",
      "url": "https://finnhub.io/api/news?id=5e67508313d3e187e7ee03353f332bc35d051e413737d2462afcd29d794a49c4"
    }
  }
]